Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core–Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy

出版年份 2020 全文链接

标题

作者

关键词

出版物

Volume 12, Issue 51, Pages 57362-57372

出版商

American Chemical Society (ACS)

发表日期

2020-12-11

DOI

10.1021/acsami.0c17660

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now